Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:00 PM
Ignite Modification Date:
2025-12-24 @ 7:00 PM
NCT ID:
NCT00447057
Eligibility Criteria:
Inclusion Criteria:
* Histological or cytological diagnosis of locally advanced or metastatic NSCLC that is of nonsquamous histology and not amenable to curative therapy.
* Failure of previous treatment with one prior platinum-based chemotherapy regimen.
* Good performance status.
* Adequate bone marrow reserve, renal and hepatic functions.
Exclusion Criteria:
* Serious concomitant systemic disease.
* Inability to take oral medication.
* Inability or unwillingness to take vitamin supplementation and corticosteroids.
* Pregnancy / Breast-feeding.
* Treatment with certain medicines that prevent blood from clotting.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00447057
Study Brief:
Protocol Section:
NCT00447057